Management Strategies to Facilitate Optimal Outcomes for Patients Treated with Delayed-release Dimethyl Fumarate

Overview of attention for article published in Drug Safety, December 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 2 X users

patent: 2 patents

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 19 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Pharmaceutical compositions comprising the PPAR agonist INT-131 and Nrf2 activators

Grant US-11484530-B2

United States of America

Pharmaceutical compositions comprising glitazones and NRF2 activators

Grant US-10426763-B2

United States of America